Eagle Rock Investment Company LLC Has $9.22 Million Stake in HCA Healthcare, Inc. $HCA

Eagle Rock Investment Company LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 36.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 21,632 shares of the company’s stock after selling 12,481 shares during the period. HCA Healthcare accounts for 1.4% of Eagle Rock Investment Company LLC’s portfolio, making the stock its 20th largest holding. Eagle Rock Investment Company LLC’s holdings in HCA Healthcare were worth $9,220,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Brighton Jones LLC bought a new stake in HCA Healthcare in the fourth quarter worth $1,021,000. NewEdge Advisors LLC increased its holdings in shares of HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares during the last quarter. Sivia Capital Partners LLC lifted its holdings in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Quotient Wealth Partners LLC raised its position in shares of HCA Healthcare by 22.2% in the second quarter. Quotient Wealth Partners LLC now owns 1,057 shares of the company’s stock valued at $405,000 after purchasing an additional 192 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of HCA Healthcare during the 2nd quarter worth $109,337,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.9%

NYSE HCA opened at $539.91 on Monday. The company has a 50 day moving average of $482.80 and a 200-day moving average of $449.62. The firm has a market cap of $120.73 billion, a price-to-earnings ratio of 19.02, a PEG ratio of 1.66 and a beta of 1.36. HCA Healthcare, Inc. has a 1-year low of $295.00 and a 1-year high of $552.90.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the previous year, the business posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a $0.78 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the sale, the senior vice president owned 44,379 shares in the company, valued at $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 13,520 shares of company stock worth $6,894,067. Insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on HCA shares. UBS Group upped their price target on shares of HCA Healthcare from $525.00 to $598.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Argus raised their target price on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a report on Friday, February 6th. Royal Bank Of Canada upped their price target on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. KeyCorp set a $503.00 price objective on HCA Healthcare in a research report on Wednesday, January 28th. Finally, Cantor Fitzgerald upped their target price on HCA Healthcare from $525.00 to $588.00 and gave the company an “overweight” rating in a research note on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $523.27.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s share performance is strong on a year‑over‑year basis (shares up ~75% YoY), reinforcing momentum and investor confidence in the company’s results and outlook. Read More.
• Positive Sentiment: Zacks and other analysts highlight earnings growth and price strength; Zacks added HCA to focus coverage and raised FY‑2026 EPS estimates, supporting forward earnings momentum and valuation. Read More.
• Positive Sentiment: HCA raised its quarterly dividend (new quarterly payout announced), which narrows yield risk and is a modest positive for income‑oriented investors. Read More.
• Positive Sentiment: Large institutional flows and stake increases (e.g., Norges Bank, Pacer, Viking Global) point to strong institutional demand and provide technical/supportive buying pressure for the stock. Read More.
• Neutral Sentiment: HCA completed a 43‑hospital EHR rollout and is tracking success metrics — operational execution that can improve efficiency and integration over time but has a gradual, not immediate, earnings impact. Read More.
• Neutral Sentiment: Local expansion moves — HCA Houston Healthcare Tomball acquired Supreme Care ER and StoneSprings plans a freestanding ER conversion — small, market‑level capacity adds that could modestly lift volumes in those geographies. Read More.
• Neutral Sentiment: HCA sold ASC real estate — a financing/portfolio move that could free capital or change lease terms; impact depends on transaction use of proceeds. Read More.
• Negative Sentiment: Insider selling: two senior VPs disclosed multi‑million dollar sales (Christopher Wyatt sold ~$2.0M; Jennifer Berres sold ~$4.13M). Significant insider sales can create short‑term selling pressure or raise governance/portfolio‑rebalancing questions. Read More. Read More.
• Negative Sentiment: Zacks/other outlets flagged a downward revision to HCA’s Q1 EPS forecast, which can pressure near‑term expectations even as FY estimates were raised. Read More.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.